FOI Response14 Aug 2024 10:26
On 2 August 2024, I sent the following questions to Southampton University clinical trials department:
"I have three questions about the UNIVERSAL clinical trial.
1. What is Sanofi's role in the clinical trial?
2. Are they funding the trial?
3. Is the trial still active or inactive?"
This morning, on 14 August 2024, I received the following reply in a PDF (dated 6 August 2024) attached to the email:
"In accordance with Section 1(1)(a) of the Act, we confirm that the University holds the information of the description specified in your request.
1. What is Sanofi's role in the clinical trial?
Response: Sanofi are a party in a sub-project of the overall trial. Title is “Detection of Bordetella pertussis signal within an adult UK population hospitalized with acute respiratory syndrome – Pilot data collection”.
2. Are they funding the trial?
Response: Sanofi are funding the sub-project.
3. Is the trial still active or inactive?
Response: The trial is active."